Exploring Blockchain for the Future of FDA Data Exchange

The Food and Drug Administration’s Office of Innovation is looking for an enterprise blockchain solution that can meet the needs of use cases agencywide. Steven Hubbard, the office’s senior technical adviser, said the technology has potential to help the agency securely exchange the data it receives faster — including adverse event data or regulation packages that require review.

Leveraging the cloud is also part of FDA’s strategic plan, from infrastructure to platform-as-a-service. For the Office of Innovation, that means sandboxing ideas to figure out how to get certain solutions to meet FDA’s needs, faster.